<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Salivary adenoid cystic carcinoma with an early phase of high-grade transformation: case report with an immunohistochemical analysis.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Salivary adenoid cystic carcinoma with an early phase of high-grade transformation: case report with an immunohistochemical analysis." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b0/3737055/43fd1181564a/1746-1596-8-113-5.jpg"/> </div> <div class="text-side"> <h1>Salivary adenoid cystic carcinoma with an early phase of high-grade transformation: case report with an immunohistochemical analysis.</h1> <p>Results of the immunohistochemical examination of high-grade carcinoma component in the present case. Typical AdCC area showed low labeling index for Ki-67, whereas the high-grade carcinoma component (asterisk) showed a high Ki-67 labeling index (A: immunostaining x20). The high-grade carcinoma component also showed strong and diffuse positivity for p53 (B: immunostaining x200: inset; weakly positive for p53 in typical AdCC), Her-2 (C; inset; weakly positive for Her-2 in typical AdCC: immunostaining x400), p16 (D: immunostaining x200: inset; focally positivity for p16 in typical AdCC; immunostaining x400), and cyclin A (E; immunostaining x200: inset; focally positivity for cyclin A in typical AdCC; immunostaining x400), respectively.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/23819679/" target="_blank">23819679</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>